STAGE IIIA SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8
Clinical trials for STAGE IIIA SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIA SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo aims to boost immune attack on sarcoma before surgery
Disease control OngoingThis early-phase study tests the safety of combining two immunotherapy drugs—nivolumab and BO-112—given before surgery for soft tissue sarcoma that can be removed. About 14 adults with certain sarcoma types will receive these drugs to see if they help the immune system fight the …
Matched conditions: STAGE IIIA SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could fewer radiation sessions mean fewer complications for sarcoma patients?
Disease control OngoingThis phase 2 trial is testing a shorter, higher-dose radiation schedule given before surgery for soft tissue sarcoma of the arms, legs, or trunk. The goal is to see if this approach reduces wound complications after surgery while still controlling the cancer. About 122 patients a…
Matched conditions: STAGE IIIA SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC